Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Santoni-Rugiu

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Journal of Thoracic Disease|June 17, 2026
Are lazertinib and osimertinib comparable for treating advanced <i>EGFR</i>-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA studyEdyta Maria Urbanska, Eric Santoni-Rugiu, Morten Grauslund, et al.
Respiratory Medicine Case Reports|May 3, 2018
Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)Marta E Gajewska, Sajitha S Sritharan, Eric Santoni-Rugiu, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 21, 2010
Ossifying thymoma associated with refractory myasthenia gravisEric Santoni-Rugiu, Jesper Ravn, Maxwell Sehested, et al.
Journal of Pathology Informatics|October 21, 2022
Lost in digitization - A systematic review about the diagnostic test accuracy of digital pathology solutionsOlsi Kusta, Charlotte Vestrup Rift, Torsten Risør, et al.
Oncotarget|June 15, 2018
Concomitant driver mutations in advanced <i>EGFR</i>-mutated non-small-cell lung cancer and their impact on erlotinib treatmentJan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, et al.
Ugeskrift for Laeger|September 1, 2015
[Unexpected bronchoscopic findings in sarcoidosis]Magnus Gottlieb, Michael Perch, Eric Santoni-Rugiu, et al.
Anticancer Research|June 13, 2014
Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancerAdam Vilmar, Eric Santoni-Rugiu, Jesus Garcia-Fon Cillas, et al.
Ugeskrift for Laeger|February 2, 2024
Katia Damsgaard Højsager, Hanne Kobberø, Eric Santoni-Rugiu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest GroupDavid B Chapel, Andrew Churg, Eric Santoni-Rugiu, et al.
International Journal of Molecular Sciences|April 25, 2020
Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of <i>ALK</i>-Rearranged NSCLC: <i>ALK</i>- and <i>BRAF</i>-Mutations Followed by Epithelial-Mesenchymal TransitionEdyta M Urbanska, Jens B Sørensen, Linea C Melchior, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Journal of Thoracic Disease|June 17, 2026
Are lazertinib and osimertinib comparable for treating advanced <i>EGFR</i>-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA studyEdyta Maria Urbanska, Eric Santoni-Rugiu, Morten Grauslund, et al.
Respiratory Medicine Case Reports|May 3, 2018
Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)Marta E Gajewska, Sajitha S Sritharan, Eric Santoni-Rugiu, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 21, 2010
Ossifying thymoma associated with refractory myasthenia gravisEric Santoni-Rugiu, Jesper Ravn, Maxwell Sehested, et al.
Journal of Pathology Informatics|October 21, 2022
Lost in digitization - A systematic review about the diagnostic test accuracy of digital pathology solutionsOlsi Kusta, Charlotte Vestrup Rift, Torsten Risør, et al.
Oncotarget|June 15, 2018
Concomitant driver mutations in advanced <i>EGFR</i>-mutated non-small-cell lung cancer and their impact on erlotinib treatmentJan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, et al.
Ugeskrift for Laeger|September 1, 2015
[Unexpected bronchoscopic findings in sarcoidosis]Magnus Gottlieb, Michael Perch, Eric Santoni-Rugiu, et al.
Anticancer Research|June 13, 2014
Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancerAdam Vilmar, Eric Santoni-Rugiu, Jesus Garcia-Fon Cillas, et al.
Ugeskrift for Laeger|February 2, 2024
Katia Damsgaard Højsager, Hanne Kobberø, Eric Santoni-Rugiu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest GroupDavid B Chapel, Andrew Churg, Eric Santoni-Rugiu, et al.
International Journal of Molecular Sciences|April 25, 2020
Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of <i>ALK</i>-Rearranged NSCLC: <i>ALK</i>- and <i>BRAF</i>-Mutations Followed by Epithelial-Mesenchymal TransitionEdyta M Urbanska, Jens B Sørensen, Linea C Melchior, et al.
Pageof 10